Perceptions of prognostic risks in chronic kidney disease: A national survey

Canadian Journal of Kidney Health and Disease

Volumn 2, Issue 1, 2015, Pages

  Chiu, Helen H L ^a,b   Tangri, Navdeep ^c   Djurdjev, Ognjenka ^c,d   Barrett, Brendan J ^e   Hemmelgarn, Brenda R ^f   Madore, François ^g   Rigatto, Claudio ^c   Muirhead, Norman ^h   Sood, Manish M ⁱ   Clase, Catherine M ^j   Levin, Adeera ^b,k  

^a PROVIDENCE HEALTH CARE RESEARCH INSTITUTE   (Canada)

^b BC Provincial Renal Agency   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d PROVINCIAL HEALTH SERVICES AUTHORITY   (Canada)

^e MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^f FOOTHILLS HOSPITAL   (Canada)

^g UNIVERSITÉ DE MONTRÉAL   (Canada)

^h UNIVERSITY OF WESTERN ONTARIO   (Canada)

ⁱ OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^j MCMASTER UNIVERSITY   (Canada)

^k UNIVERSITY OF BRITISH COLUMBIA   (Canada)

more..

Author keywords

Chronic kidney disease; Decision making; Risk perception; Risk prediction models; Time frames

Indexed keywords

ADVERSE OUTCOME; ARTERIOVENOUS FISTULA; ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL DECISION MAKING; DIALYSIS; GLOMERULUS FILTRATION RATE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; PERCEPTION; PRIORITY JOURNAL; RISK ASSESSMENT; WEB BASED SURVEY;

EID: 84999018445     PISSN: None     EISSN: 20543581     Source Type: Journal    
DOI: 10.1186/s40697-015-0088-z     Document Type: Article

References (43)

1. Arora P, Vasa P, Brenner D, Iglar K, McFarlane P, Morrison H, et al. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. Can Med Assoc J. 2013;185(9):E417-23.
2. Levin A, Hemmelgarn B, Culleton B, Tobe S, McFarlane P, Ruzicka M, et al. Guidelines for the management of chronic kidney disease. Can Med Assoc J. 2008;179(11):1154-62.
3. Stigant C, Stevens L, Levin A. Nephrology: 4. Strategies for the care of adults with chronic kidney disease. Can Med Assoc J. 2003;168(12):1553-60.
4. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296-305.
5. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al. Chronic kidney disease as a global public health problem: approaches and initiatives-a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007;72(3):247-59.
6. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension. 2003;42(5):1050-65.
7. Bradbury BD, Fissell RB, Albert JM, Anthony MS, Critchlow CW, Pisoni RL, et al. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol. 2007;2(1):89-99.
8. Ocak G, Halbesma N, le Cessie S, Hoogeveen EK, van Dijk S, Kooman J, et al. Haemodialysis catheters increase mortality as compared to arteriovenous accesses especially in elderly patients. Nephrol Dial Transplant. 2011;26(8):2611-7.
9. National Kidney Foundation Vascular Access Work Group. Clinical practice guidelines for vascular access. Am J Kidney Dis. 2006;48 Suppl 1:S248-73.
10. Jindal K, Chan CT, Deziel C. Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol. 2006;17(3 Suppl 1):S1-27.
11. Mustafa RA, Zimmerman D, Rioux JP, Suri RS, Gangji A, Steele A, et al. Vascular access for intensive maintenance hemodialysis: a systematic review for a Canadian Society of Nephrology clinical practice guideline. Am J Kidney Dis. 2013;62(1):112-31.
12. Lazarides MK, Georgiadis GS, Antoniou GA, Staramos DN. A meta-analysis of dialysis access outcome in elderly patients. J Vasc Surg. 2007;45(2):420-6.
13. Komenda P, Copland M, Er L, Djurdjev O, Levin A. Outcomes of a provincial home haemodialysis programme-a two-year experience: establishing benchmarks for programme evaluation. Nephrol Dial Transplant. 2008;23(8):2647-52.
14. Sood M, Manns B, Dart A, Hiebert B, Kappel J, Komenda P, et al. Variation in the level of eGFR at dialysis initiation across dialysis facilities and geographic regions. Clinc J Am Soc Nephrol. 2014;9(10):1747-56.
15. Canadian Institute for Health Information. The Canadian Organ Replacement Register. 2013.
16. Davison R, Sheerin NS. Prognosis and management of chronic kidney disease (CKD) at the end of life. Postgrad Med J. 2014;90(1060):98-105.
17. Tangri N, Kitsios GD, Inker LA, Griffith J, Naimark DM, Walker S, et al. Risk prediction models for patients with chronic kidney disease: a systematic review. Ann Intern Med. 2013;158(8):596-603.
18. Atkinson R, Flint J. Snowball Sampling. In: Lewis-Beck M, Bryman A, Liao T, editors. The SAGE Encyclopedia of Social Science Research Methods. Thousand Oaks: Sage Publications, Inc; 2004. p. 1044-5.
19. Manns B, Barrett B, Evans M, Garg A, Hemmelgarn B, Kappel J, et al. Establishing a national knowledge translation and generation network in kidney disease: the CAnadian KidNey KNowledge TraNslation and GEneration NeTwork. Can J Kidney Health Dis. 2014;1(1):2.
20. Eckardt KU, Barthlein B, Baid-Agrawal S, Beck A, Busch M, Eitner F, et al. The German chronic kidney disease (GCKD) study: design and methods. Nephrol Dial Transplant. 2012;27(4):1454-60.
21. Feldman HI, Appel LJ, Chertow GM, Cifelli D, Cizman B, Daugirdas J, et al. The chronic renal insufficiency cohort (CRIC) study: design and methods. J Am Soc Nephrol. 2003;14(7 Suppl 2):S148-53.
22. Levin A, Rigatto C, Brendan B, Madore F, Muirhead N, Holmes D, et al. Cohort profile: Canadian study of prediction of death, dialysis and interim cardiovascular events (CanPREDDICT). BMC Nephrol. 2013;14:121.
23. Li L, Astor BC, Lewis J, Hu B, Appel LJ, Lipkowitz MS, et al. Longitudinal progression trajectory of GFR among patients with CKD. Am J Kidney Dis. 2012;59(4):504-12.
24. Fox CS, Matsushita K, Woodward M, Bilo HJ, Chalmers J, Heerspink HJ, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet. 2012;380(9854):1662-73.
25. Bhavsar NA, Appel LJ, Kusek JW, Contreras G, Bakris G, Coresh J, et al. Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD. Am J Kidney Dis. 2011;58(6):886-93.
26. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837-47.
27. The Nurses' Health Study: Publication [http://www.channing.harvard.edu/nhs/?page_id=154. Accessed 5 May 2015.]
28. The Cardiovascular Health Study: Published Papers [http://www.chs-nhlbi.org/Papers.htm. Accessed 5 May 2015.]
29. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002;106(25):3143-421.
30. Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS, et al. The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol. 2007;50(3):217-24.
31. Levin A, Chaudhry MR, Djurdjev O, Beaulieu M, Komenda P. Diabetes, kidney disease and cardiovascular disease patients. Assessing care of complex patients using outpatient testing and visits: additional metrics by which to evaluate health care system functioning. Nephrol Dial Transplant. 2009;24(9):2714-20.
32. Razavian M, Heeley EL, Perkovic V, Zoungas S, Weekes A, Patel AA, et al. Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study). Nephrol Dial Transplant. 2012;27(4):1396-402.
33. Tonelli M, Gill J, Pandeya S, Bohm C, Levin A, Kiberd BA. Slowing the progression of chronic renal insufficiency. CMAJ. 2002;166(7):906-7.
34. Xi W, MacNab J, Lok CE, Lee TC, Maya ID, Mokrzycki MH, et al. Who should be referred for a fistula? A survey of nephrologists. Nephrol Dial Transplant. 2010;25(8):2644-51.
35. O'Hare AM, Batten A, Burrows NR, Pavkov ME, Taylor L, Gupta I, et al. Trajectories of kidney function decline in the 2years before initiation of long-term dialysis. Am J Kidney Dis. 2012;59(4):513-22.
36. Schell JO, O'Hare AM. Illness trajectories and their relevance to the care of adults with kidney disease. Curr Opin Nephrol Hypertens. 2013.
37. Xi W, Harwood L, Diamant MJ, Brown JB, Gallo K, Sontrop JM, et al. Patient attitudes towards the arteriovenous fistula: a qualitative study on vascular access decision making. Nephrol Dial Transplant. 2011;26(10):3302-8.
38. Reinke LF, Engelberg RA, Shannon SE, Wenrich MD, Vig EK, Back AL, et al. Transitions regarding palliative and end-of-life care in severe chronic obstructive pulmonary disease or advanced cancer: themes identified by patients, families, and clinicians. J Palliat Med. 2008;11(4):601-9.
39. Ortendahl M. Shared decision-making based on different features of risk in the context of diabetes mellitus and rheumatoid arthritis. Ther Clin Risk Manag. 2007;3(6):1175-80.
40. Davison SN. End-of-life care preferences and needs: perceptions of patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010;5(2):195-204.
41. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67(6):2089-100.
42. Ludlow MJ, George CR, Hawley CM, Matthew TH, Agar JW, Kerr PG, et al. How Australian nephrologists view home dialysis: results of a national survey. Nephrol. 2011;16(4):446-52.
43. Davison SN, Jhangri GS, Holley JL, Moss AH. Nephrologists' reported preparedness for end-of-life decision-making. Clin J Am Soc Nephrol. 2006;1(6):1256-62.